Your browser doesn't support javascript.
loading
Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19).
Lakatos, Botond; Kowalska, Justyna; Antoniak, Sergii; Gokengin, Deniz; Begovac, Josip; Vassilenko, Anna; Wasilewski, Piotr; Fleischhans, Lukas; Jilich, David; Matulionyte, Raimonda; Kase, Kerstin; Papadopoulus, Antonios; Rukhadze, Nino; Harxhi, Arjan; Hofman, Sam; Dragovic, Gordana; Vasyliev, Marta; Verhaz, Antonija; Yancheva, Nina; Oprea, Cristiana.
Affiliation
  • Lakatos B; HIV Center, National Institute of Hematology and Infectious Diseases, South Pest Central Hospital, Budapest, Hungary.
  • Kowalska J; Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.
  • Antoniak S; Viral Hepatitis and AIDS Department at the Gromashevsky Institute of Epidemiology and Infectious Diseases, Kyiv, Ukraine.
  • Gokengin D; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.
  • Begovac J; School of Medicine, University Hospital for Infectious Diseases, University of Zagreb, Zagreb, Croatia.
  • Vassilenko A; Global Fund Grant Management Department, Republican Scientific and Practical Center for Medical Technologies, Minsk, Belarus.
  • Wasilewski P; 4th Department, Hospital for Infectious Diseases in Warsaw, Warsaw, Poland.
  • Fleischhans L; Department of Infectious Diseases, 1st Faculty of Medicine, Charles University in Prague and Faculty Hospital Bulovka, Bulovka, Czech Republic.
  • Jilich D; Department of Infectious Diseases, 1st Faculty of Medicine, Charles University in Prague and Faculty Hospital Bulovka, Bulovka, Czech Republic.
  • Matulionyte R; Faculty of Medicine, Vilnius University, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Kase K; West Tallinn Central Hospital, Tallinn, Estonia.
  • Papadopoulus A; Medical School, National and Kapodistrian University of Athens, University General Hospital Attikon, Athens, Greece.
  • Rukhadze N; Infectious Diseases, AIDS and Clinical Immunology Center, Tbilisi, Georgia.
  • Harxhi A; Infectious Disease Service, University Hospital Center of Tirana, Tirana, Albania.
  • Hofman S; Faculty of Medicine in Plzen, Charles University, University Hospital Plzen, Plzen, Czech Republic.
  • Dragovic G; Department of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine, University of Belgrade, Belgrade, Serbia.
  • Vasyliev M; Astar Medical Center, Lviv, Ukraine.
  • Verhaz A; Department for Infectious Diseases, Faculty of Medicine, University of Banja Luka, Republika Srpska, Banja Luka, Bosnia and Herzegovina.
  • Yancheva N; Department for AIDS, Specialized Hospital for Active Treatment of Infectious and Parasitic Disease Sofia, Sofi, Bulgaria.
  • Oprea C; Carol Davila University of Medicine and Pharmacy, Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.
HIV Med ; 23(6): 693-700, 2022 07.
Article in En | MEDLINE | ID: mdl-34859557
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: HIV Infections / HIV Seropositivity / Anti-HIV Agents / COVID-19 Drug Treatment Type of study: Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Type: Article Affiliation country: Hungary
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: HIV Infections / HIV Seropositivity / Anti-HIV Agents / COVID-19 Drug Treatment Type of study: Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Type: Article Affiliation country: Hungary